Showing results (81-90 of 290) with videos related to
Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancerNaiyer A Rizvi, Gregory J Riely, Christopher G Azzoli, et al.The Oncologist|July 12, 2019
Pan-Cancer Analysis of <i>CDK12</i> Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator PhenotypeEthan S Sokol, Dean Pavlick, Garrett M Frampton, et al.Cancer Discovery|May 31, 2014
Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusionsChristine M Lovly, Abha Gupta, Doron Lipson, et al.Lung Cancer (Amsterdam, Netherlands)|August 22, 2020
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profilingRussell Madison, Alexa B Schrock, Emily Castellanos, et al.The Annals of Thoracic Surgery|November 21, 2002
Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinomaMichael I Ebright, Maureen F Zakowski, Jocelyne Martin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinomaGregory J Riely, Mark G Kris, Daniel Rosenbaum, et al.JAMA Oncology|June 16, 2017
Genomic Profiling of Small-Bowel AdenocarcinomaAlexa B Schrock, Craig E Devoe, Robert McWilliams, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trialsDavid M Jackman, Vincent A Miller, Leigh-Anne Cioffredi, et al.European Urology Focus|August 31, 2020
Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial CarcinomaAndrea Necchi, Russell Madison, Sumanta K Pal, et al.Cancer|August 1, 2006
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancerDaniel T Milton, Christopher G Azzoli, Robert T Heelan, et al.Pageof 29